CN Stock MarketDetailed Quotes
300267 Hunan Er-kang Pharmaceutical
- 3.08
- +0.12+4.05%
Market Closed Nov 19 15:00 CST
6.35BMarket Cap-24444P/E (TTM)
3.11High2.90Low439.51KlotVolume2.96Open2.96Pre Close130.96MTurnover3.09%Turnover RatioLossP/E (Static)2.06BShares3.7352wk High1.34P/B4.38BFloat Cap2.0352wk Low3.55Limit Up1.42BShs Float23.06Historical High2.37Limit Down7.10%Amplitude1.20Historical Low--Dividend TTM2.98Avg Price188.44KlotAsk--Div YieldTTM100Lot Size242.94KlotBid
Hunan Er-kang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -42.99%854.08M | -40.67%610.23M | -50.44%262.69M | -3.48%1.77B | 16.96%1.5B | 22.81%1.03B | 31.32%530.04M | -25.35%1.84B | -19.21%1.28B | -5.45%837.56M |
| Refunds of taxes and levies | 1,298.61%23.61M | 1,363.65%23.61M | 46.85%1.93M | -48.60%14.05M | -93.29%1.69M | -92.90%1.61M | -89.04%1.31M | -14.48%27.34M | -14.23%25.14M | 224.31%22.71M |
| Cash received relating to other operating activities | -73.86%74.4M | -74.52%43.68M | -59.82%31.64M | -2.28%413.84M | -36.06%284.59M | -36.70%171.41M | -55.27%78.73M | 251.49%423.5M | 475.21%445.07M | 579.18%270.81M |
| Cash inflows from operating activities | -46.64%952.09M | -43.62%677.52M | -51.44%296.26M | -3.80%2.2B | 1.90%1.78B | 6.24%1.2B | 3.12%610.09M | -12.47%2.29B | 3.49%1.75B | 21.26%1.13B |
| Goods services cash paid | -61.55%438.22M | -56.68%333.84M | -55.61%190.26M | -11.69%1.24B | 12.20%1.14B | 22.42%770.61M | 46.22%428.58M | -21.47%1.41B | -3.06%1.02B | 24.18%629.48M |
| Staff behalf paid | -1.48%126.15M | -5.05%87.82M | 0.83%49.82M | -8.59%166.59M | -10.83%128.04M | -9.31%92.5M | -14.77%49.41M | 1.48%182.24M | 6.04%143.6M | 11.20%102M |
| All taxes paid | -1.75%50.34M | 70.00%37.72M | -2,069.36%-3.85M | 198.84%72.06M | 25.14%51.24M | -26.51%22.19M | -97.98%195.62K | -76.48%24.11M | -50.74%40.94M | -49.84%30.19M |
| Cash paid relating to other operating activities | -46.42%261.56M | -65.84%90.51M | -80.66%49.33M | 44.68%575M | 20.74%488.14M | -12.07%264.97M | 169.20%255.12M | -12.09%397.42M | 77.71%404.29M | 164.14%301.34M |
| Cash outflows from operating activities | -51.51%876.28M | -52.19%549.89M | -61.06%285.56M | 2.27%2.05B | 12.62%1.81B | 8.21%1.15B | 60.98%733.3M | -20.39%2.01B | 7.41%1.6B | 37.53%1.06B |
| Net cash flows from operating activities | 434.97%75.81M | 148.54%127.63M | 108.68%10.7M | -47.18%148.42M | -115.44%-22.63M | -24.55%51.35M | -190.51%-123.2M | 203.20%281.02M | -26.07%146.6M | -57.42%68.06M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -73.09%210.43M | -76.57%150.43M | -81.64%100.43M | -44.00%833.35M | -25.02%782M | 0.00%642M | 154.42%547M | -59.54%1.49B | -62.43%1.04B | -65.78%642M |
| Cash received from returns on investments | -91.30%1.9M | -30.38%1.51M | -57.83%654.71K | -2.13%12.81M | 127.25%21.83M | -75.58%2.16M | 215.48%1.55M | -24.00%13.09M | -24.94%9.6M | -6.78%8.86M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.10%181.3K | -99.25%150K | --150K | 4,927.96%20.11M | 38,579.01%20.11M | 62,412.50%20M | ---- | -67.71%400.03K | 16,973.25%52K | 166.67%32K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | --348K | --348K | ---- | -57.14%1.42M | ---- | ---- |
| Cash received relating to other investing activities | --705K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -74.13%213.22M | -77.11%152.09M | -81.54%101.24M | -42.36%866.27M | -21.69%824.29M | 2.09%664.52M | 154.56%548.55M | -59.38%1.5B | -62.31%1.05B | -65.50%650.89M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -7.65%164.31M | -1.23%99.23M | -5.69%51.67M | 37.29%238.19M | 96.59%177.92M | 39.89%100.47M | 14.97%54.79M | -50.34%173.49M | -69.55%90.5M | -65.91%71.82M |
| Cash paid to acquire investments | -58.26%310.2M | -58.52%250.2M | -53.92%250.2M | -53.84%733M | -48.79%743.12M | -6.49%603.12M | 23.97%543M | -52.21%1.59B | -49.64%1.45B | -67.28%645M |
| Cash outflows from investing activities | -48.48%474.51M | -50.34%349.43M | -49.50%301.87M | -44.87%971.19M | -40.25%921.04M | -1.85%703.59M | 23.09%597.79M | -52.81%1.76B | -51.50%1.54B | -67.14%716.82M |
| Net cash flows from investing activities | -170.04%-261.29M | -405.04%-197.34M | -307.50%-200.63M | 59.43%-104.92M | 80.21%-96.76M | 40.73%-39.07M | 81.78%-49.24M | -679.39%-258.58M | -26.81%-488.85M | 77.64%-65.93M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 210.81%307.7M | 160.30%257.7M | 221.84%157.7M | -9.49%341M | -64.23%99M | -64.23%99M | -78.39%49M | -4.86%376.75M | -30.11%276.75M | -30.11%276.75M |
| Cash received relating to other financing activities | 1,108.39%200M | 1,108.39%200M | 807.17%150.14M | --146.59M | --16.55M | --16.55M | --16.55M | ---- | ---- | ---- |
| Cash inflows from financing activities | 339.37%507.7M | 296.10%457.7M | 369.63%307.84M | 29.42%487.59M | -58.25%115.55M | -58.25%115.55M | -71.09%65.55M | -5.02%376.75M | -30.23%276.75M | -30.23%276.75M |
| Borrowing repayment | -7.54%259M | -7.54%259M | -35.25%149M | 54.53%380.13M | 13.88%280.13M | 13.88%280.13M | 15.07%230.13M | -59.87%246M | -59.87%246M | -46.87%246M |
| Dividend interest payment | -89.36%7.32M | -90.95%6.19M | -39.68%3.35M | 1,382.81%70.1M | 2,406.84%68.82M | 3,113.31%68.41M | 248.19%5.55M | -95.89%4.73M | -97.58%2.75M | -98.08%2.13M |
| Cash payments relating to other financing activities | 3,773.43%103.2M | 2,504.44%51.16M | 124.00%611.73K | 50.21%203.36M | -83.75%2.66M | -87.23%1.96M | -66.90%273.1K | 3,303.87%135.39M | 2,395.63%16.39M | --15.38M |
| Cash outflows from financing activities | 5.09%369.53M | -9.75%316.35M | -35.17%152.96M | 69.27%653.6M | 32.62%351.62M | 33.02%350.51M | 16.57%235.95M | -47.24%386.12M | -63.54%265.14M | -54.08%263.51M |
| Net cash flows from financing activities | 158.53%138.17M | 160.16%141.35M | 190.89%154.89M | -1,672.01%-166.01M | -2,132.83%-236.07M | -1,874.04%-234.96M | -800.33%-170.4M | 97.21%-9.37M | 103.51%11.61M | 107.47%13.24M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -309.43%-9.55M | -8,736.62%-7.92M | -104.06%-5.85M | -98.90%201.12K | -111.89%-2.33M | -99.32%91.69K | -86.08%-2.86M | 714.14%18.3M | 1,303.65%19.62M | 807.76%13.46M |
| Net increase in cash and cash equivalents | 84.11%-56.85M | 128.63%63.73M | 88.17%-40.89M | -489.88%-122.3M | -15.04%-357.79M | -871.80%-222.59M | -210.77%-345.71M | 111.25%31.37M | 40.11%-311.01M | 109.18%28.84M |
| Add:Begin period cash and cash equivalents | -19.32%510.64M | -19.32%510.64M | -19.32%510.64M | 5.21%632.94M | 5.21%632.94M | 5.21%632.94M | 5.21%632.94M | -31.66%601.57M | -31.66%601.57M | -31.66%601.57M |
| End period cash equivalent | 64.93%453.79M | 39.97%574.37M | 63.54%469.74M | -19.32%510.64M | -5.31%275.15M | -34.91%410.35M | -41.42%287.23M | 5.21%632.94M | -19.51%290.56M | 11.36%630.41M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data